Genetic variation supports a causal role for valproate in prevention of ischemic stroke

Valproate is a candidate for ischemic stroke prevention due to its anti-atherosclerotic effects in vivo. Although valproate use is associated with decreased ischemic stroke risk in observational studies, confounding by indication precludes causal conclusions. To overcome this limitation, we applied...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayerhofer, Ernst, Parodi, Livia, Narasimhalu, Kaavya, Wolking, Stefan, Harloff, Andreas, Georgakis, Marios K, Rosand, Jonathan, Anderson, Christopher D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980256/
https://www.ncbi.nlm.nih.gov/pubmed/36865155
http://dx.doi.org/10.1101/2023.02.14.23285856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980256/
https://www.ncbi.nlm.nih.gov/pubmed/36865155
http://dx.doi.org/10.1101/2023.02.14.23285856

Ejemplares similares